Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 24 | $8,521,337 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 900 | 335.1459 | 301,631 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,777 | 336.7795 | 598,457 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,146 | 338.091 | 387,452 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 400 | 339.6843 | 135,874 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,657 | 340.7525 | 564,627 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,043 | 341.8376 | 356,537 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,077 | 342.8967 | 369,300 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 4,701 | 343.8479 | 1,616,429 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,412 | 344.757 | 486,797 | D |
| 04 Mar 2025 21:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2025 | Sale | 1,052 | 340.9857 | 358,717 | D |
| 04 Mar 2025 21:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2025 | Sale | 175 | 341.5491 | 59,771 | D |
| 27 Jan 2025 17:03 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 24 Jan 2025 | Sale | 103 | 335.24 | 34,530 | D |
| 17 Jan 2025 19:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 17 Jan 2025 | Sale | 442 | 273.41 | 120,847 | D |
| 18 Jun 2024 21:39 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | Sale | 1,900 | 280 | 532,000 | D |
| 14 Jun 2024 21:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Jun 2024 | Sale | 2,000 | 285 | 570,000 | D |
| 23 May 2024 21:36 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 21 May 2024 | Sale | 1,036 | 231.34 | 239,668 | D |
| 18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 15 Dec 2023 | Sale | 1,000 | 241 | 241,000 | D |
| 18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 15 Dec 2023 | Sale | 1,000 | 236 | 236,000 | D |
| 18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Dec 2023 | Sale | 1,000 | 232 | 232,000 | D |
| 18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Dec 2023 | Sale | 1,000 | 233 | 233,000 | D |
| 14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 13 Dec 2023 | Sale | 1,000 | 226 | 226,000 | D |
| 14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Dec 2023 | Sale | 800 | 219 | 175,200 | D |
| 14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 13 Dec 2023 | Sale | 1,500 | 225 | 337,500 | D |
| 14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Dec 2023 | Sale | 500 | 216 | 108,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)